IKBKB and primary cutaneous T-cell non-Hodgkin lymphoma: The top-ranked drugs suggestive for PSC included denileukin diftitox, interleukin-2-alpha binder used for cutaneous T-cell lymphoma (z = −5.443); vitamin E (z = −1.918); MLN0415, a small molecule IKK2 inhibitor downregulating the expression of a number of inflammatory proteins (z = −1.648).